Personalized Management of Head and Neck Cancer

Key Information

Price: £155

EISBN: 978-1-78084-192-2

Edited by Theresa L Whiteside

Overview

This book of nine chapters from international experts provides an overview of head and neck cancer – the sixth cause of cancer deaths worldwide. Coverage includes etiology, risk factors, diagnosis, classification, prevalence and prognostic biomarkers. The book highlights available therapeutic options, including radiotherapy, surgery, chemotherapy and molecularly targeted therapies. With the notable exception of anti-EGF receptor antibody therapy (covered in two chapters), immunotherapy in head and neck cancer has lagged behind relative to other solid tumors. The editor highlights how, in future, immunotherapy alone or in various combinations will likely become a widely accepted paradigm for treatment. The closing chapter indicates how consensus or clinical practice guidelines have become increasingly more important in optimizing healthcare practices.